Good afternoon and welcome to Markets Desk, your midday read on what's moving and why.
Earnings season continues to drive the tape, and Motorola Solutions turned in a strong third quarter of twenty twenty six, with the public safety technology giant posting results that reinforced its position as a reliable compounder. Demand for its land mobile radio systems and video security platforms remains firm, and management's tone on forward guidance was notably confident, suggesting enterprise and government spending has not softened meaningfully despite broader macro uncertainty.
Shifting to biotech, Revolution Medicines delivered a closely watched third quarter call as the RAS-focused oncology company continues advancing its pipeline toward pivotal readouts. Investors are paying close attention to cash runway and clinical milestones, and the company's commentary on its combination therapy approach in solid tumors gave the market enough to stay constructive on the name heading into year end.
And on the macro side, gasoline prices are showing signs of easing, with two analysts flagging the potential for the national average to fall below four dollars a gallon in the near term. The key variable is the Middle East, specifically the Iran conflict. Any de-escalation removes a significant geopolitical premium from crude, and that flows directly and quickly to the pump.
That's the tape. Markets Desk, signing off the floor.
